Holen Sie sich die Stockscreener-App
1.50
1.32%
-0.02
Handel nachbörslich:
1.50
Schlusskurs vom Vortag:
$1.52
Offen:
$1.5
24-Stunden-Volumen:
73,697
Relative Volume:
0.99
Marktkapitalisierung:
$11.51M
Einnahmen:
$598.00K
Nettoeinkommen (Verlust:
$-44.93M
KGV:
-0.1805
EPS:
-8.31
Netto-Cashflow:
$-17.32M
1W Leistung:
-5.36%
1M Leistung:
-25.37%
6M Leistung:
-68.24%
1J Leistung:
-94.62%
1-Tages-Spanne:
$1.48
$1.5599
1-Wochen-Bereich:
$1.48
$1.70
52-Wochen-Spanne:
$1.48
$28.80
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Firmenname
Ernexa Therapeutics Inc
Sektor
Branche
Telefon
(617) 798-6700
Adresse
1035 CAMBRIDGE STREET, CAMBRIDGE
Vergleichen Sie ERNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.50 | 11.85M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc Aktie (ERNA) Neueste Nachrichten
Ernexa Therapeutics Inc. stock trend outlook and recovery pathWeekly Profit Analysis & Community Supported Trade Ideas - Newser
Screener Results Flag Ernexa Therapeutics Inc. as OversoldInsider Buying & Community Shared Stock Ideas - newsyoung.net
Price action breakdown for Ernexa Therapeutics Inc.Earnings Overview Report & Safe Entry Momentum Stock Tips - Newser
Full technical analysis of Ernexa Therapeutics Inc. stockJuly 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Using economic indicators to assess Ernexa Therapeutics Inc. potentialQuarterly Performance Summary & Daily Volume Surge Signals - Newser
What’s next for Ernexa Therapeutics Inc. stock priceEarnings Growth Report & Community Trade Idea Sharing - Newser
What moving averages say about Ernexa Therapeutics Inc.Quarterly Growth Report & Expert Curated Trade Setups - Newser
What does recent volatility data suggest for Ernexa Therapeutics Inc.July 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Ernexa Therapeutics Inc. stock outlook for YEAR2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser
Is Ernexa Therapeutics Inc. forming a bottoming baseQuarterly Trade Review & Weekly Market Pulse Updates - Newser
Analyzing recovery setups for Ernexa Therapeutics Inc. investorsJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - Newser
How institutional ownership impacts Ernexa Therapeutics Inc. stock2025 Market Outlook & Verified Momentum Stock Alerts - Newser
Long term hold vs stop loss in Ernexa Therapeutics Inc.July 2025 Outlook & Weekly Return Optimization Alerts - Newser
Will Ernexa Therapeutics Inc. stock benefit from AI tech trends2025 Market Outlook & Growth Oriented Trading Recommendations - beatles.ru
What are the future prospects of Ernexa Therapeutics Inc.Portfolio Performance Summary & Pattern Based Trade Signal System - 선데이타임즈
Real time breakdown of Ernexa Therapeutics Inc. stock performanceQuarterly Performance Summary & Daily Market Momentum Tracking - Newser
Should you hold or exit Ernexa Therapeutics Inc. nowCEO Change & AI Forecasted Entry/Exit Points - Newser
What to expect from Ernexa Therapeutics Inc. in the next 30 days2025 Analyst Calls & Weekly High Momentum Picks - Newser
Using Bollinger Bands to evaluate Ernexa Therapeutics Inc.Weekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
Why Ernexa Therapeutics Inc. stock attracts strong analyst attention2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
Is Ernexa Therapeutics Inc. showing signs of accumulation2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
Is Ernexa Therapeutics Inc. stock forming a triangle patternJuly 2025 Big Picture & Reliable Price Breakout Alerts - mustnews.co.kr
Using data models to predict Ernexa Therapeutics Inc. stock movementProduct Launch & Short-Term Trading Opportunity Alerts - Newser
Institutional scanner results for Ernexa Therapeutics Inc.Weekly Trend Recap & Accurate Technical Buy Alerts - Newser
Detecting price anomalies in Ernexa Therapeutics Inc. with AIBreakout Watch & Verified High Yield Trade Plans - Newser
Using R and stats models for Ernexa Therapeutics Inc. forecastingJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - Newser
Can Ernexa Therapeutics Inc. deliver alphaRate Hike & Low Drawdown Momentum Trade Ideas - thegnnews.com
Will Ernexa Therapeutics Inc. continue its uptrendTrade Risk Assessment & Capital Efficiency Focused Ideas - Newser
Can Traders Expect Breakout From Ernexa Therapeutics Inc. This WeekQuarterly Profit Summary & Daily Profit Maximizing Trade Tips - classian.co.kr
Is Ernexa Therapeutics Inc. still worth holding after the dipJuly 2025 Action & Free Growth Oriented Trading Recommendations - Newser
Ernexa Therapeutics Inc.’s Price Action Aligns with Quant Signals2025 Volume Leaders & High Win Rate Trade Tips - sundaytimes.kr
Why Ernexa Therapeutics Inc. is moving todayBull Run & Free Weekly Watchlist of Top Performers - Newser
What MACD signals say about Ernexa Therapeutics Inc.CEO Change & AI Driven Price Predictions - Newser
Regression Model Predicts Rangebound Movement in Ernexa Therapeutics Inc.Quarterly Market Summary & Weekly High Conviction Trade Ideas - newsyoung.net
Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ernexa Therapeutics Inc-Aktie (ERNA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cherington Charles | 10% Owner |
Apr 02 '25 |
Buy |
0.10 |
3,768,397 |
394,174 |
20,401,602 |
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):